Winton Capital »

Parabilis Medicines shares owned by Winton Capital

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $955k 35k 27.37

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines